New diabetes clinical trial: Dapagliflozin, Spironolactone or Both for HFpEF

Published on: January 09, 2023 at 11:00AM
Condition:   Heart Failure With Preserved Ejection Fraction
Interventions:   Drug: Dapagliflozin;   Drug: Spironolactone;   Drug: Spironolactone + Dapagliflozin
Sponsors:   Universidade do Porto;   Centro Hospitalar De São João, E.P.E. (CHUSJ);   Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.
Recruiting
https://ift.tt/XSeG7i4